PD 535 40 (Accupril 40 mg)
Generic Name: quinapril
Pill with imprint PD 535 40 is Brown, Elliptical / Oval and has been identified as Accupril 40 mg. It is supplied by Parke-Davis.
Accupril is used in the treatment of high blood pressure; diabetic kidney disease; left ventricular dysfunction; heart failure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Accupril 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PD 535 40
Accupril
- Generic Name
- quinapril
- Imprint
- PD 535 40
- Strength
- 40 mg
- Color
- Brown
- Size
- 15.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Angiotensin Converting Enzyme Inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Parke-Davis
- Inactive Ingredients
-
candelilla wax, magnesium carbonate, magnesium stearate, ferric oxide red, titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00071-0535 | Pfizer Inc. |
| 54868-3445 | Physicians Total Care Inc. (repackager) |
| 55289-0555 | PDRX Pharmaceuticals Inc. (repackager) |
| 63874-0058 | Altura Pharmaceuticals Inc. (repackager) |
More about Accupril (quinapril)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 3 Reviews
- Generic Availability
- Drug class: Angiotensin Converting Enzyme Inhibitors
- FDA Alerts (1)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
